482. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
作者: Laura J Esserman.;Allison S Fiscalini.;Arash Naeim.;Laura J Van't Veer.;Andrea Kaster.;Maren T Scheuner.;Andrea Z LaCroix.;Alexander D Borowsky.;Hoda Anton-Culver.;Olufunmilayo I Olopade.;James Esserman.;Rachael Lancaster.;Lisa Madlensky.;Amie M Blanco.;Katherine S Ross.;Deborah L Goodman.;Barry S Tong.;Michael Hogarth.;Diane Heditsian.;Susie Brain.;Vivian Lee.;Kelly Blum.;Mi-Ok Kim.;Leah P Sabacan.;Kirkpatrick B Fergus.;Christina Yau.;Hannah L Park.;Barbara A Parker.;Celia Kaplan.;Kim F Rhoads.;Suzanne Eder.;Kelly Adduci.;Jeffrey B Matthews.;Neil S Wenger.;Yiwey Shieh.;Robert A Hiatt.;Elad Ziv.;Jeffrey A Tice.;Martin Eklund.
来源: JAMA. 2026年335卷9期763-774页
Individual breast cancer risk can guide screening initiation, frequency, use of supplemental imaging, and preventive measures to improve breast cancer screening by shifting resources from low-risk women to high-risk women.
|